• Nov 20, 2017

    Updates on Technology and Testing in Pathology (On-Demand)

    CME 1 AMA PRA Category 1 Credit - Non-Physician |CME 1 AMA PRA Category 1 Credit
    Non Member: $35.00

    Updates on Technology & Testing in Pathology

    Pathology consultation is geared toward providing useful information to assist in the provision of optimal care. This webinar will cover laboratory aspects of the evaluation of lower genital tract disease.  Topics to be covered include: types of HPV testing available, handling of biopsy and excision specimens to obtain the best report possible, molecular testing and immunohistochemistry, and areas of diagnostic difficulty.

     

    Speaker

            

    Dr. Heller received her medical training at New York Medical College and completed her residency in Obstetrics and Gynecology at Beth Israel Medical Center in New York.  Her education continued at Mount Sinai School of Medicine where she completed both a residency in Anatomic Pathology, and fellowships in Gynecological Pathology and Pediatric Pathology. She is a diplomate in Pediatric Pathology, Anatomic Pathology, and Obstetrics & Gynecology. Dr. Heller is Professor with tenure of Pathology & Laboratory Medicine, with joint appointments in the Department of Pediatrics, as well as the Department of Obstetrics, Gynecology and Women’s Health at Rutgers-NJ Medical School. Dr. Heller is the author of over 240 published articles as well as books and book chapters on issues relating to gynecologic oncology and poor pregnancy outcomes relating to placental disease. She serves as an Associate Editor for the Journal of Lower Genital Tract Disease and is a member of the ASCCP Practice Committee.

           

    Registration Cost

    ASCCP Members: FREE
    Non-Members: $35.00

    Continuing Medical Education Credit

    Target Audience

    This activity is intended for obstetricians, gynecologists, family and internal medicine practitioners, pathologists and other healthcare practitioners involved in the treatment and care of gynecology patients.

    Objectives

    At the end of this activity, participants should be able to:

    • Describe the features of the commonly available HPV tests

    • Understand what part clinicians play in ensuring optimum pathology consultation

    • Develop familiarity with the workings of the pathology laboratory, and how this impacts diagnosis

    • Describe the uses of the immune-histochemical and molecular tests utilized by the pathologist in the evaluation of lower genital tract disease

    Accreditation Statement

    The ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Physician Credit Designation

    ASCCP - The American Society for Colposcopy and Cervical Pathology designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure Information

    As an accredited provider of CME credit, ASCCP is required to comply with the ACCME's Standards for Commercial Support and has implemented a management process to ensure that anyone in a position to affect the content of the educational activity (e.g., faculty, planners, etc.) disclosed all relevant financial relationships with a commercial interest and ensured that those relationships do not influence presentation materials. All faculty have agreed to base their presentations on best available evidence. ASCCP discloses to learners any financial relationship(s) to healthcare-related commercial interests existing within the past 12 months to include the following information: 

    1. the name of the individual;
    2. the name of the commercial interest; and,
    3. the nature of the relationship the person has with each commercial interest.

    Slides and slide notes are reviewed for possible bias prior to the activity's release by the Accreditation Committee and peer-reviewers, and potential conflicts of interest are resolved prior to the live presentation. Any discussion of off-label use of products is noted when appropriate, as is discussion of any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Disclosures of these commitments and/or relationships are published in these lecture materials and provided prior to the start of the activity, so the learners may formulate their own judgments regarding the presentation(s). Under ASCCP policy, anyone declining either to disclose or amend material to eliminate potential bias identified by the Accreditation Committee will be replaced.

    Author, Reviewer, and Planner Disclosure Information:

    The following are all reported disclosures of interest or potential conflicts from the 12 months preceding this activity.

    Those reporting no financial relationships or conflict of interest to disclose:

    • Debra Heller, MD (Speaker)
    • Michael Policar, MD, MPH (Reviewer)
    • Kerry O. Curtis (ASCCP Executive Director, Planner)
    • Alisha Yocum (ASCCP Director of Membership & Marketing, Planner)
    • Mary K. Stanley (ASCCP Director of Education, Planner)
    • Christina Arnold (ASCCP Education Manager, Planner)

    This webinar is supported by an independent educational grant from BD Diagnostics.